We investigated the influence of the antiepileptic drugs carbamazepine (CBZ), phenytoin (PHT) 
Introduction
Antiepileptic drugs modify either neurotransmission or membrane conductance in order to reduce the likelihood of epileptic seizures. For most of these drugs the underlying mechanism is not completely clear. It may involve the modification of transmitter function or may influence a variety of different membrane channels or both (Macdonald and Kelly, 1994) . The drug with the best known mechanism is vigabatrin, which enhances the gamma-aminobutyric acid (GABA) concentration at the receptor level by irreversible inhibition of the GABA decomposing enzyme gammaaminotransaminase.
Antiepileptic drugs also modify the function of neurons not involved in epileptogenesis, e.g. in trigeminal neuralgia. We tried to uncover differential drug effects by testing visual © Oxford University Press 1996 functions, thereby aiming particularly at retinal neurons which ontogenetically are part of the brain. Investigation of retinal and higher visual function and dysfunction by psychophysical or electrophysiological methods may reveal functional processes within the brain by non-invasive methods. Parkinson's disease is a well-known degenerative condition which also involves retinal dopaminergic neurons. Although the visual deficits are not severe enough to produce subjective visual complaints, the comparatively simple retinal anatomy and physiology allows a realistic modelling of the responsible dopaminergic mechanisms (Bodis-Wollner and Yahr, 1978; Bodis-Wollner, 1990; Tagliati et al., 1994) .
In the present study we used three different psychophysical methods to assess visual function in patients on three standard antiepileptic drugs. First, the well-known Farnsworth 100 HUE test was used as a time-consuming, but commonly available reference for the description of a colour perception deficit (Pokomy et al., 1979) . Secondly, we used sinusoidal colour and black-white gratings, as well as Gaussian filtered dots, in order to assess impairment of achromatic and chromatic visual perception which, in turn, may be related to the function of the parvocellular (achromatic and chromatic) and magnocellular (achromatic) and of on-centre and off-centre pathways of the retina. Thirdly, blue test light increment and postadaptation threshold measurements on a yellow background were investigated. When subtracting the increment threshold from the postadaptation threshold, a transient threshold increase by about one log unit occurs for blue with an exponential decline in ~l-2 s. This phenomenon of transient blue blindness was first observed by Stiles (1949) . Mollon and Polden (1977) studied it extensively and named it transient tritanopia. This is a paradoxical phenomenon, since at the offset of the adapting yellow light one would expect the threshold to fall immediately for blue. Neural interactions are very likely to be involved. Adaptation of the blue sensitive cones can be excluded as a source for this effect, since the wavelength of the yellow adapting light (575 run) is too long to stimulate the blue sensitive cones.
Transient tritanopia is regarded as a rather specific test for neurotransmission, since it has been related to the function of the so-called cone-triad in the outer plexiform layer of the retina (Zrenner, 1983) or at least in the retina itself (Pokorny and Smith, 1995) . Two transmitters, glutamate and GAB A are involved in the signal processing within this triad. Glutamate has consistently been found in rod as well as in cone pedicles and appears to be the major transmitter of the vertical pathway, e.g. the majority of bipolar and ganglion cells (Davanger et al., 1991; Crooks and Kolb, 1992) . In a previous study we found an increment threshold increase in Huntington's disease, which we suggested was due to a glutaminergic deficit in the retina (Paulus et al., 1993) .
The aim of these investigations was to evaluate in vivo methods which allow testing of transmitter or channel function as sensitive and as specific as possible and, in addition, to supply qualitative and quantitative information on the effects of classical antiepileptic drugs in the human CNS.
Patients and methods
Forty-one patients on three different drugs to treat their epilepsy participated in the study after giving their informed consent according to the declaration of Helsinki. AJ1 patients were on monotherapy. All antiepileptic drug plasma levels were taken on the day of the investigation. All patients except two in the VPA group suffered from a pharmcoresistent partial epilepsy. About 90% were unsuitable for epilepsy surgery due to a long history and multiregional EEG changes. Patients were not investigated on the days following a complex partial seizure nor after a generalized seizure. The younger normal subjects were mostly students, and the older age group also included neurological patients with unrelated disorders such as vertebral disc protrusions without drug therapy. Due to the long duration of the psychophysical investigations some sessions had to be terminated early. Therefore the number of patients investigated varies slightly in the subgroups. A visual acuity below 0.6 or more than one error in discrimination of the 24 plates edition of the Ishihara test served as exclusion criteria for subjects and patients with congenital colour blindness. In order to minimize fatigue artifacts, the investigations were interrupted at regular intervals. (Luneau Ophthalmologie, Paris) This test demands the proper arrangement of 85 coloured caps encompassing a desaturated version of each spectral colour and the purple line. The light source was a Macbeth easel lamp with a daylight filter (D65). Although normative data have been published by several authors (i.e. Pokorny et al., 1979) , we have established our own control data by incorporating our normal subjects into the performance of this test
Farnsworth Munsell 100 Hue Test

Sinusoidal gratings and Gaussian dots
We used the computerized Moorfields Vision System to drive a 980X600 pixel Barco colour monitor with a frame rate of 90 Hz. Details of the method have been published elsewhere in investigations of Parkinson's disease (Haug et al., 1994 (Haug et al., , 1995 . Vertical sinusoidal gratings were investigated with spatial frequencies of 8.5, 6.15, 4.1 and 2.05 cycles deg" 1 in 102 normals with a mean age of 33±9 years, 14 patients on CBZ (age 33 ±9 years), 16 patients on PHT (age 29 ±9 years) and 9 patients on VPA (age 23±5 years). Gaussian dots were looked at in 47 normals (age 28 ±12 years), 15 patients on CBZ (age 32±9 years), 14 patients on PHT (age 31 ±10 years) and 12 patients on VPA (age 23 ±4 years). We investigated four different dot sizes: size 1 = 0.13°; size 2 = 0.43°; size 3 = 1.32°; size 4 = 4.1°. The perceptual size of the dots was measured at 10% contrast level. The colours were the same for dots and gratings with the following CIE 1931 coordinates provided by the Barco monitor for white (Y = 23 cd nr 2 ; x = 0.350, v = 0.366) and for full saturation of the four colours (blue: x = 0.2229, y = 0.3022; red: x = 0.5109, y = 0.3902; green: x = 0.3471, y = 4838; yellow: x = 0.4438, v = 0.4457). We measured chromatic discrimination thresholds for gratings and dots by increasing the colour saturation of each colour against the equiluminant white background by using a two-alternative forced choice method. Colour contrast threshold (Figs 2-4) was measured as percent along the straight lines between the system endpoints of the colour axes.
Increment and postadaptation thresholds
We measured the increment threshold of a blue test (1°d iameter, 500 ms duration) light during adaptation to a yellow background, and then monitored the paradoxical threshold increase of the blue test light after turning off the yellow adaptation light. Details of the method have already been published (Paulus et al., 1993) . The apparatus (Retinal Function Test Instrument, Nidek, Japan) presents stimuli in Maxwellian view with an artificial pupil of 1.5 mm diameter. The major advantage of this method is that the light beam is smaller than the natural pupil and the retinal illumination is kept constant without the need for artificial pupil dilatation. The major disadvantage is that the patient is required to look through a small aperture of an optical system and not at a distant visual target. Only one eye can be tested at a time.
Thresholds of the blue test light were determined using a staircase procedure for five defined yellow background light intensities [11 000, 1500, 110, 75, 10 troland (td) ]. The investigation started with a 2-min adaptation to the yellow background light. The investigator increased or decreased the blue test light intensity in steps of 0.1 log units according to the observers answers. Ascending and descending thresholds did not differ by more than 0.2 steps and therefore threshold was defined by their mean values. This procedure was repeated five times after 5 s readaptation. After adaptation to the background light for a further 2 min, blue thresholds were measured in the same way, now 50 ms after the background was switched off with a test stimulus duration of 450 ms. An overall time-limit was not imposed. During the experiment the patients were continuously monitored and encouraged by the investigating physician. If the visual image disappeared with eye or head movements the ongoing trial was terminated and repeated.
Seventy-five subjects of different ages served as a control example, for the red dot size 1 a significant effect of PHT on the threshold could be demonstrated (P < 0.0001) which was absent for VPA.
(mean age 33 ±14 years). In order to account for an age effect, all data are presented with the age plotted on the abscissa. The statistics also took the age effect into account. Fifteen patients on CBZ (age 35 ±13 years), 14 patients on PHT (age 27±8 years) and seven on VPA (28.6±13 years) were investigated. The mean plasma levels were: 11.26±3.04 iigml" 1 for CBZ, 17.73±7.7^gml-' for PHT and 65.31 ±18.5 Hg ml" 1 for VPA.
Statistics
In order to account for the age dependency of the data we chose for statistical analysis a two-dimensional linear regression model with age and disease as independent parameters and the thresholds as dependent parameter (Allen and Cady, 1982; SAS/STAT, 1988; Paulus et al., 1993 ). An F test (mean square for the model/mean square for the error) was used to check how well the model explains the data. Only when the significance probability F(t) associated with the F statistic was <0.02 was the model accepted. Both F(t) and the significance level of the drug effect have been plotted in the tables.
Results
Farnsworth D100
We investigated 39 normals (age 31 ±13 years), 14 patients on CBZ (31 ±9 years), 10 patients on PHT (29±10 years) and seven patients on VPA (24±5 years). The total error score in all three patient groups was significantly elevated. Phenytoin produced the largest score and VPA the next largest, with a slightly higher score than CBZ. The significance values for this test and the three drugs investigated are shown in Table 1 . In order to detect selective affection of particular colours, we calculated a grand average of these data and plotted the results in the standard circle diagram of the D100. No clear colour preponderance was found for the three drugs ( Fig. 1) .
Gaussian dots and sinusoidal gratings
The study performed with the monitor system revealed two essentially normal results. First, the CBZ group did not deviate from the normals in any test of this group, therefore these data have been omitted in Table 2 . Secondly, no difference to the normal group was found when investigating colour or black-white sinusoidal gratings of each spatial frequency. Therefore these data too were not entered into Table 2 . However, the results of black-white gratings must be analysed with caution. When their intensity modulation is generated by a 3X8 bit graphics card providing 256 intensity steps, the luminance resolution of the visual system surpasses the resolution of the monitor for medium spatial frequencies. Therefore, we cannot exclude the possibility that subtle differences for the black-white gratings may have been overlooked due to this resolution problem. We have discussed this problem elsewhere (Haug et al., 1994) . Since the colour perception threshold is higher, this problem did not occur for the colour gratings. Altogether, the gratings could be detected better than the Gaussian dots, which was, at least in part, caused by the borders at the top and the bottom of the gratings since they were not Gaussian filtered. This better detectablity may obscure subtle drug effects. Table 2 depicts the statistical results of each Gaussian dot stimulus in the PHT and VPA patients groups. The left part of each column represents F(t) for the test, values <0.02 being chosen as the criterion for the validity of the test for these data. For F(t) <0.02, the significance level for the drug effect was plotted in the right column, otherwise the test was not valid and the right column was marked with a dash. Figure 2 shows the blue Gaussian thresholds of size 3 for patients (closed circles) and normals (open circles) plotted against age (x axis) for CBZ. This figure is representative of the 24 different investigations in the CBZ group whose results were consistently negative across all tests. Phenytoin consistently elevated Gaussian thresholds for any colour of each size tested, in contrast to CBZ. As an example for PHT, the green Gaussian thresholds of size 3 are again plotted for patients and normals against age (Fig. 3) .
In the VPA group, blue Gaussian dots turned out to be the most sensitive test and achromatic luminance decrements the least sensitive test. For blue dots, the thresholds of all dot sizes were significantly increased. For the luminance decrements the thresholds did not change. For the remaining colours and for white increments it turned out that the larger dots, in particular, could be significantly less well detected when patients were on VPA. As an example, the threshold increase for the yellow Gauss of size 3 is shown here (Fig. 4) . Age (years) Fig. 4 Example graph of colour contrast thresholds for yellow Gaussian dots of size 3 plotted against age for patients on VPA (closed circles) and the normal group (open circles). Valproic acid induced a threshold increase for all the blue Gaussian dots, for the two larger dot sizes for green, red, yellow and achromatic increment, but not for Gaussian achromatic decrements {see Table 2 ).
Increment threshold, postadaptation threshold and transient tritanopia
adaptation threshold and the transient tritanopia effect as the difference between both may be pathological in any combination. Again, CBZ did not elevate any of the thresholds. Phenytoin did not enhance the increment threshold and, except for the highest luminance level, did not enhance the postadaptation threshold either. Except for the lowest luminance level it did, however, consistently elevate transient tritanopia thresholds. Figure 5 shows this effect by demonstrating increment thresholds, postadaptation thresholds and transient tritanopia effects for the blue test light at a background illumination level of 110 td (adaptation level 3). Figure 6 demonstrates the same investigations at a background illumination level of 11 000 td (adaptation level 5). In addition to the results in Fig. 5 , a significant difference (P < 0.005) emerged between normals and patients on PHT both for the postadaptation threshold and the transient tritanopia effect (bottom).
Patients on VPA showed a rather consistent increase in increment thresholds at each of the five adaptation levels without a concomitant increase in postadaptation threshold. The only example which was accepted with a significance level of 0.0225 is the increment threshold at level 3, otherwise only levels better than 0.02 have been used in this paper. Figure 7 illustrates the threshold increase for increment thresholds at the four lower adaptation levels (Fig. 7) . Figure 8 demonstrates the behaviour of patients on VPA at the highest adaptation level. In addition to the consistent increment thresholds increase they also had a significant postadaptation threshold elevation. When subtracting the increment threshold increase from the postadaptation threshold increase, both effects cancel and result in a normal transient tritanopia effect (Fig. 8) . Table 3 ) between normals and patients on PHT was only found for the transient tritanopia effect.
Discussion
We have studied the effect of three commonly used antiepileptic drugs on visual perception using three different methods. Quantitative as well as qualitative differences between the effect of the drugs could be demonstrated. The Famsworth D100 was the most sensitive test for the detection of a colour discrimination deficit. It requires the proper arrangement of 85 colour caps in four boxes. Only when performing this test, the CBZ group performed significantly worse than the control group. The major disadvantage of this test is the time-consuming procedure. It takes up to 8 min to arrange the colour caps with a long time to analyse the data afterwards. We cannot, therefore, exclude the possibility that attentional difficulties are involved since this test also has a motor compound in manipulating the colour caps. Our assumption that the effects are generated with high probability in the visual system and are caused by the drugs is, however, supported by the Gaussian dot results. Here too the CBZ group performed best, the PHT group worst with the VPA group in between. In an additional analysis of data, not reported here in detail, we have seen a clear correlation between plasma levels and visual thresholds for PHT and for VPA which documents the causal relationship between drug effect and psychophysics but may also indicate intrusion of cognitive effects. There is an ongoing debate concerning differential cognitive impairment caused by different antiepileptic drugs. In general these studies are inconclusive. 'Apparently, the only information that we have is that the differential impact of PHT and CBZ on cognitive function is not extremely different' (Aldenkamp and Vermeulen, 1995) . Also, 'in general, the cognitive profile of the two antiepileptic drugs CBZ and VPA was the same, except for some attention and memory aspects on which the VPA subjects scored better and for some motor tests which the CBZ group performed faster' (Coenen et al., 1995) . This, we believe, further supports our arguments that we have measured rather specific effects in the visual system. The Farnsworth D100 results lacked colour specificity. In the grand averages of the total error scores no clear colour preponderance could be detected for the different drugs. This has been proposed previously for the D100 (Bayer et al., 1991) . Unspecific affection of colour perception was further confirmed by similar Gaussian dot threshold elevations for the four main colours (red, green, blue and yellow) within each drug group. Gaussian dot thresholds were not elevated at all in patients on CBZ; they were not elevated for the larger size dots of all colours in patients on VPA; they were elevated for all dot sizes and all colours for patients on PHT. Thus we conclude that PHT impairs both red-green and blue-yellow colour vision more than VPA, whereas CBZ induces rather small effects.
Colour specific threshold elevations only occurred in the VPA group for blue and red when reducing the dot sizes. In our opinion this finding is not sufficient to support the assumption of selective red-blue threshold elevations, since for these smaller dot sizes the effect of higher spatial frequency transmission introduces a more complex interaction between colour and spatial frequency transmission (Paulus and Kroger-Paulus, 1983; Paulus et al., 1986) . Both findings, better separation with larger dot sizes and with colour compared with luminance, may be explained by the different processing of colour compared with luminance by retinal parvocellular cells. Colour stimulates each cell more vigorously than luminance (Paulus et al., 1986) . Impairment of the response characteristic of these cells may affect colour perception more than luminance perception.
We have made every effort to avoid false positive or negative differences by (i) investigating our own control group for the Farnsworth D100, (ii) using the MacBeth Easel lamp for illumination, (iii) equilibrating the colour luminance, (iv) using statistical methods which take the effect of age into account, and (v) assuring comparable plasma drug levels for the three groups. It might be argued that the pathological results, particularly for PHT, could be due to an unspecific toxicity. This seems to be unlikely given that the mean plasma level was in the normal range. Furthermore, it is unlikely that unspecific toxicity would result in such specific effects which we observed with the Maxwellian view system in the PHT group.
Predominant affection of one colour system is possible as we have shown with the dopaminergic deficit in Parkinson's disease. Using the same monitor system we found a predominant affection of blue-yellow in contrast to redgreen perception (Haug et al., 1995) , in accordance with reports of other groups (Price et al., 1992) . A preponderance of blue-yellow affection can be explained by well-known anatomical and physiological differences between the blueyellow and red-green systems which have been investigated in detail (e.g. Ahnelt and Kolb, 1995) . The blue-yellow system is also more vulnerable to diffuse retinal lesions (DeMonasterio et al., 1981) . The unique transmitter deficit of dopamine in Parkinson's disease has also allowed the development of rather specific psychophysical concepts and techniques which allow monitoring of the function of certain cell groups (Bodis-Wollner and Yahr, 1978) , techniques which are still rudimentary for other transmitter systems. The dopaminergic function of the responsible dopaminergic interplexiform retinal cells (Dacey, 1990) has been monitored by using gratings with high spatial and temporal frequency (Bodis-Wollner, 1990 ). This spatiotemporal frequency domain is affected as a result of dopaminergic influence on the functional coupling of centre and surround activity of bipolar and ganglion cells at an early retinal stage. Furthermore, psychophysical or neurophysiological techniques enable investigators to differentiate between D1 and D2 receptors when a corresponding selective receptor antagonist can be used (Tagliati et al., 1994) . The complex pharmacological profile of standard antiepileptic drugs is difficult to relate to the function of retinal or higher level cells of the visual system. Non-specific threshold increases in colour arrangement tests or colour threshold detection tests such as Gaussian dots mainly serve to detect and quantify the perceptual deficit. The qualitative differences between PHT (mainly increase in transient tritanopia) and VPA (mainly increment threshold increase) which we have seen with increment thresholds and postadaptation diresholds are more likely to correlate with specific aspects of retinal or, much less likely, cerebral neurotransmission (Zrenner, 1983; Pokorny and Smith, 1995) . Although we used a blue test light on a yellow background we do not think that the effects measured are specific for the blue-yellow system. The reason why this stimulus combination is also frequently used by other authors is the very small absorption sensitivity of blue cones for the longer wavelengths (Bayer, 1991) . This gives almost selective stimulation of the long-wavelength sensitive receptive field 
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surround of a blue-yellow unit, without significantly affecting the centre. Due to the overlapping spectral sensitivities, this is more difficult to achieve with the centre/surround selectivity by using red-green or achromatic stimuli (Reeves and Wu, 1995) . Thus, we interpret our findings as changes in the dynamic antagonism of centre and surround of retinal units assuming that red-green opponent units behave in a similar manner.
We found a significant increase of increment threshold at four out of five background luminance levels in patients on VPA. Postadaptation thresholds were only elevated at the highest luminance level in patients on VPA and PHT and only the PHT group showed a consistent threshold elevation at the upper four levels for the transient tritanopia effect in contrast to the VPA group who showed the effect at levels three and four.
It is tempting to correlate these threshold changes with retina] signal processing. Horizontal cells are responsible for lateral inhibition and are engaged in the invaginating synapses in photoreceptor pedicles. Physiologically they are nonspiking neurons and, at least in non-mammalian vertebrates, they have an unusual non-Ca 2+ -triggered, but voltagedependent transmitter release. They contact non-specifically all three types of cone (Dacey and Lee, 1995) . H-cells are hyperpolarized by yellow light which stimulates L and M cones. They have a sign-inverting input into blue cones. The H-cell to B-cone transmitter is thought to be GABA (Wassle and Chun, 1989; Wassle and Boycott, 1991) which is released in darkness. Yellow light hyperpolarizes the middle and long wave cones in the receptive field surround and, concurrently, the horizontal cells, which stops the release of the transmitter GABA. This, in turn, depolarizes the B-cone by decreasing its Cl~or K + conductance so that it can reach a more positive resting potential. Consequently the continuous activity of the ganglion cell is decreased. This, in turn, leads to an enhancement of blue receptor sensitivity to incoming blue light by enhancing the response gain.
The decrease in blue light sensitivity, observed as transient tritanopia in healthy observers after switching off longwavelength adaptation, can be attributed to a rebound depolarization of the long-wavelength cones and an even stronger transient depolarization of the horizontal cell, which in turn is suggested to release the hyperpolarizing transmitter GABA on to the B-cone's submembrane. Explanations for the threshold increases produced by antiepileptic drugs thus have to take into account GABAergic and glutaminergic transmitter effects and influences on Cl" or K + , or other membrane conductances.
Transient tritanopia is best elicited with high adaptation levels (Zrenner, 1983) . This is in accordance with changes of centre and surround interactions from pure absolute threshold detection to Weber fraction behaviour with increasing adaptation level (Pokorny and Smith, 1995) . Also in this study, increment thresholds and postadaptation thresholds behaved differently at different luminance levels, which requires further studies of neurotransmission. In addition to transmitter effects, gap junctions also have to be taken into account; they may couple at lower luminance where spatial averaging would improve contrast sensitivity without cost to spatial acuity (Tsukamoto et al., 1992) .
At present it is difficult to relate the obvious differences in the behaviour of the three drugs to transmitter or channel effects. According to Macdonald and Kelly (1994) , PHT and CBZ both act in a rather similar way on Na + channels without influencing GABA receptors or T-Ca 2+ channels. In addition, PHT improves Cl~ conductance in cortical neurons (DeLorenzo, 1995) . The discrepancies between PHT and VPA are easier to explain since, in addition to Na + channel activation, it has been suggested that sodium valproate activates GABA receptors and T-Ca 2+ channels (MacDonald and Kelly, 1994) . Further studies are necessary with more specific drugs. At present, we hypothesize that investigation of the adaptation behaviour of the retina offers the best promise to further elucidate in vivo action of antiepileptic drugs affecting neurotransmission. Experiments designed to stimulate mainly off-centre cells could enable investigators to trace the lack of a difference in the achromatic Gaussian dot decrements (Table 2) for VPA and, concomitantly, the different neurotransmitters found in the off-and on-centre pathways in the human and primate retina, respectively (Davanger et al., 1991; Crooks and Kolb, 1992) , where on-and off-bipolar cells express fundamentally different glutamate receptors in their membranes (Grunert et al., 1994) .
